Press release
Alcoholic Hepatitis Pipeline Insights 2024: Therapies, Clinical Trials, Therapeutic Advancements, MOA, ROA by DelveInsight | Gilead Sciences, Sanofi, Generon Pharma, Immuron Ltd., Intercept Pharma
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alcoholic Hepatitis pipeline constitutes 10+ key companies continuously working towards developing 10+ Alcoholic Hepatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight."Alcoholic Hepatitis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alcoholic Hepatitis Market.
The Alcoholic Hepatitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Alcoholic Hepatitis Pipeline Report: https://www.delveinsight.com/sample-request/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Alcoholic Hepatitis treatment therapies with a considerable amount of success over the years.
• Alcoholic Hepatitis companies working in the treatment market are ImmuneMed, NEXEL, Surrozen, Seal Rock Therapeutics, Intercept Pharmaceuticals, Aldeyra Therapeutics, Novartis Pharmaceuticals, and others, are developing therapies for the Alcoholic Hepatitis treatment
• Emerging Alcoholic Hepatitis therapies in the different phases of clinical trials are- Burfiralimab, NP-011, SZN 043, SRT-015, INT 787, ADX 629, Canakinuma, and others are expected to have a significant impact on the Alcoholic Hepatitis market in the coming years.
• In May 2024, DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company focused on developing epigenetic therapies to revolutionize the treatment of serious and life-threatening conditions like acute organ injury and cancer, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to larsucosterol for treating patients with severe alcohol-associated hepatitis (AH).
• In January 2024, Aldeyra Therapeutics, Inc. (Nasdaq: ALDX), a biotechnology company focused on developing innovative therapies for immune-mediated diseases, announced significant progress in its RASP modulator platform. This includes plans to submit a proposal to the FDA to expand the Phase 2 clinical trial of the investigational RASP modulator ADX-629 in Sjögren-Larsson Syndrome to include pediatric patients. Additionally, the company is initiating a Phase 2 trial of ADX-629 in moderate alcoholic hepatitis, submitting an IND application for ADX-246 to begin a Phase 1 trial with a planned expansion to atopic dermatitis patients, and preparing an IND application for ADX-248 for a Phase 1/2 trial targeting the dry form of age-related macular degeneration (AMD) and dark adaptation deficit. Aldeyra has also launched a preclinical program to explore RASP modulators in metabolic diseases.
• In November 2023, DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company specializing in epigenetic therapies for serious and life-threatening conditions such as acute organ injury and cancer, has announced topline results from its AHFIRM trial. This Phase 2b randomized, double-blind, placebo-controlled study evaluated the safety and efficacy of larsucosterol in 307 patients with severe alcohol-associated hepatitis (AH).
Alcoholic Hepatitis Overview
An immediate symptom of alcoholic liver disease is alcoholic hepatitis. Excessive alcohol consumption can cause hepatic inflammation, which can manifest clinically as liver failure, coagulopathy, encephalopathy, and jaundice. This condition can worsen and lead to multiorgan failure with a high death rate.
Get a Free Sample PDF Report to know more about Alcoholic Hepatitis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Alcoholic Hepatitis Drugs Under Different Phases of Clinical Development Include:
• Burfiralimab: ImmuneMed
• NP-011: NEXEL
• SZN 043: Surrozen
• SRT-015: Seal Rock Therapeutics
• INT 787: Intercept Pharmaceuticals
• ADX 629: Aldeyra Therapeutics
• Canakinumab: Novartis Pharmaceuticals
Alcoholic Hepatitis Route of Administration
Alcoholic Hepatitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Alcoholic Hepatitis Molecule Type
Alcoholic Hepatitis Products have been categorized under various Molecule types, such as
• Monoclonal antibody
• Small molecule
• Peptide
Alcoholic Hepatitis Pipeline Therapeutics Assessment
• Alcoholic Hepatitis Assessment by Product Type
• Alcoholic Hepatitis By Stage and Product Type
• Alcoholic Hepatitis Assessment by Route of Administration
• Alcoholic Hepatitis By Stage and Route of Administration
• Alcoholic Hepatitis Assessment by Molecule Type
• Alcoholic Hepatitis by Stage and Molecule Type
DelveInsight's Alcoholic Hepatitis Report covers around 10+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Alcoholic Hepatitis product details are provided in the report. Download the Alcoholic Hepatitis pipeline report to learn more about the emerging Alcoholic Hepatitis therapies
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Alcoholic Hepatitis Therapeutics Market include:
Key companies developing therapies for Alcoholic Hepatitis are - Gilead Sciences, Inc., Sanofi, Generon Pharmaceutical Technology (Shanghai) Co., Ltd., Immuron Ltd., and Intercept Pharmaceuticals, Inc., and others.
Alcoholic Hepatitis Pipeline Analysis:
The Alcoholic Hepatitis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Alcoholic Hepatitis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alcoholic Hepatitis Treatment.
• Alcoholic Hepatitis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Alcoholic Hepatitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Alcoholic Hepatitis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Alcoholic Hepatitis drugs and therapies
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Alcoholic Hepatitis Pipeline Market Drivers
• Increase in prevalence of alcohol related diseases, development of new strategies and viable treatment options for alcoholic hepatitis management are some of the important factors that are fueling the Alcoholic Hepatitis Market.
Alcoholic Hepatitis Pipeline Market Barriers
• However, lack of therapies to treat severe alcoholic hepatitis, complications associated with the disease and other factors are creating obstacles in the Alcoholic Hepatitis Market growth.
Scope of Alcoholic Hepatitis Pipeline Drug Insight
• Coverage: Global
• Key Alcoholic Hepatitis Companies: ImmuneMed, NEXEL, Surrozen, Seal Rock Therapeutics, Intercept Pharmaceuticals, Aldeyra Therapeutics, Novartis Pharmaceuticals, and others
• Key Alcoholic Hepatitis Therapies: Burfiralimab, NP-011, SZN 043, SRT-015, INT 787, ADX 629, Canakinumab, and others
• Alcoholic Hepatitis Therapeutic Assessment: Alcoholic Hepatitis current marketed and Alcoholic Hepatitis emerging therapies
• Alcoholic Hepatitis Market Dynamics: Alcoholic Hepatitis market drivers and Alcoholic Hepatitis market barriers
Request for Sample PDF Report for Alcoholic Hepatitis Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Alcoholic Hepatitis Report Introduction
2. Alcoholic Hepatitis Executive Summary
3. Alcoholic Hepatitis Overview
4. Alcoholic Hepatitis- Analytical Perspective In-depth Commercial Assessment
5. Alcoholic Hepatitis Pipeline Therapeutics
6. Alcoholic Hepatitis Late Stage Products (Phase II/III)
7. Alcoholic Hepatitis Mid Stage Products (Phase II)
8. Alcoholic Hepatitis Early Stage Products (Phase I)
9. Alcoholic Hepatitis Preclinical Stage Products
10. Alcoholic Hepatitis Therapeutics Assessment
11. Alcoholic Hepatitis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Alcoholic Hepatitis Key Companies
14. Alcoholic Hepatitis Key Products
15. Alcoholic Hepatitis Unmet Needs
16 . Alcoholic Hepatitis Market Drivers and Barriers
17. Alcoholic Hepatitis Future Perspectives and Conclusion
18. Alcoholic Hepatitis Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Alcoholic Hepatitis Market https://www.delveinsight.com/report-store/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Alcoholic Hepatitis Epidemiology https://www.delveinsight.com/report-store/alcoholic-hepatitis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcoholic Hepatitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
• Infusion Pumps Market: https://www.delveinsight.com/report-store/infusion-pumps-market
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-pipeline-insight
• Human Papillomavirus Hpv Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Interspinous Spacers Market: https://www.delveinsight.com/report-store/interspinous-spacers-market
• Dengue Fever Market: https://www.delveinsight.com/report-store/dengue-fever-market
• Chronic Hemodialysis Market: https://www.delveinsight.com/report-store/chronic-hemodialysis-market
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alcoholic Hepatitis Pipeline Insights 2024: Therapies, Clinical Trials, Therapeutic Advancements, MOA, ROA by DelveInsight | Gilead Sciences, Sanofi, Generon Pharma, Immuron Ltd., Intercept Pharma here
News-ID: 3816734 • Views: …
More Releases from DelveInsight Business Research

Cryopyrin-Associated Periodic Syndrome Pipeline Status 2024: Clinical Trials Ove …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cryopyrin-Associated Periodic Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Cryopyrin-Associated Periodic Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Cryopyrin-Associated Periodic Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.…

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Growth Projections 2023-20 …
DelveInsight's "Transthyretin Amyloid Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Transthyretin Amyloid Cardiomyopathy, historical and forecasted epidemiology as well as the Transthyretin Amyloid Cardiomyopathy market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Transthyretin Amyloid Cardiomyopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Transthyretin Amyloid Cardiomyopathy…

MELAS Syndrome Market Revenue to Expand Significantly by 2032, States DelveInsig …
DelveInsight's "MELAS Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the MELAS Syndrome, historical and forecasted epidemiology as well as the MELAS Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of MELAS Syndrome, offering comprehensive insights into the MELAS Syndrome revenue trends, prevalence, and treatment landscape. The…

Becker Muscular Dystrophy Market is Predicted to Exhibit Remarkable Growth Durin …
The Becker Muscular Dystrophy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Becker Muscular Dystrophy pipeline products will significantly revolutionize the Becker Muscular Dystrophy market dynamics.
DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Becker Muscular Dystrophy, historical and forecasted epidemiology as well as the Becker Muscular…
More Releases for Alcoholic
Alcoholic and Non-Alcoholic Beverages Market to Show Incredible Growth by 2027 C …
This Alcoholic and Non-Alcoholic Beverages market research performs systematic analysis of the market to provide profound perceptions, determine market situation and potent advancements and track prior market performances. There were several industries got shutdown due to the COVID-19 plague. This market report captures the considerable losses that businesses got and even guides them how to come out of this pandemic situation. As this pandemic left several adverse effects on different…
Alcoholic and Non-Alcoholic Beverages Market Research
This report studies the global Alcoholic and Non-Alcoholic Beverages market status and forecast, categorizes the global Alcoholic and Non-Alcoholic Beverages market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-alcoholic-nonalcoholic-beverages-2018-575
The major manufacturers covered in this report
Anheuser-Busch
Accolade Wines
Bacardi
Beam Suntory
Carlsberg
Constellation Brands
China Resource Enterprise
Diageo
Heineken
E. & J.…
Non-alcoholic Malt Beverages Posing a Healthy Alternative to Alcoholic Drinks Pr …
Future Market Insights (FMI) delivers key insights on the global non-alcoholic malt beverages market in its upcoming outlook titled 'Global Market Study on Non-alcoholic Malt Beverages: Pairing Options with the Flavors of Non-alcoholic Malt Beverages Likely to Please the Food Palates of Consumers'. In terms of value, the global non-alcoholic malt beverages market is projected to register a healthy CAGR of 4.0% during the forecast period, due to various factors,…
Global Alcoholic and Non-Alcoholic Beverages Market sizes, Demands and predictio …
Qyresearchreports include new market research report Global Alcoholic and Non-Alcoholic Beverages Market Professional Survey Report 2018 to its huge collection of research reports.
This report studies Alcoholic and Non-Alcoholic Beverages in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.
The Alcoholic and Non-Alcoholic Beverages market from a global perspective…
Global Alcoholic and Non-Alcoholic Beverages Market Trends, Analysis, Leading Pl …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Alcoholic and Non-Alcoholic Beverages Market Report 2018” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. The report studies the Alcoholic and Non-Alcoholic Beverages market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India,…
Alcoholic Drinks in Brazil
Latest Report on Alcoholic Drinks in Brazil
Total volume sales of alcoholic drinks continued to decline in Brazil in both the on-trade and off-trade channels in 2016. Consumers had less available income; therefore were forced to make more rational decisions on what to purchase, taking into consideration their budget and the necessity of each product. For this reason, consumption frequency reduced considerably in almost all categories, and also a downgrade to…